Kataoka Ayako, Tozaki-Saitoh Hidetoshi, Koga Yui, Tsuda Makoto, Inoue Kazuhide
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi, Fukuoka, Japan.
J Neurochem. 2009 Jan;108(1):115-25. doi: 10.1111/j.1471-4159.2008.05744.x. Epub 2008 Nov 10.
Microglia are implicated as a source of diverse proinflammatory factors in the CNS. Extracellular nucleotides are well known to be potent activators of glial cells and trigger the release of cytokines from microglia through purinergic receptors. However, little is known about the role of purinoceptors in microglial chemokine release. In this study, we found that high concentrations of ATP evoked release of CC-chemokine ligand 3 (CCL3)/macrophage inflammatory protein-1alpha from MG-5 cells, a mouse microglial cell line, and rapid up-regulation of CCL3 mRNA was elicited within 30 min of ATP stimulation. The release of CCL3 was also stimulated by 2'- and 3'-O-(4-benzoylbenzoyl) ATP, an agonist of P2X(7) receptors. Brilliant Blue G, an antagonist of P2X(7) receptors, strongly inhibited this ATP-induced CCL3 release. Similar pharmacological profile was observed in primary microglia. In MG-5 cells, ATP caused de-phosphorylation and nuclear translocation of the transcription factor nuclear factor of activated T cells (NFAT). ATP-induced NFAT de-phosphorylation was also dependent on P2X(7) receptor activation. Furthermore, ATP-induced CCL3 release and production were prevented by a selective inhibitor of NFAT. Taken together, the results of this study demonstrate an involvement of NFAT in the mechanism underlying P2X(7) receptor-mediated CCL3 release.
小胶质细胞被认为是中枢神经系统中多种促炎因子的来源。细胞外核苷酸是众所周知的胶质细胞强效激活剂,可通过嘌呤能受体触发小胶质细胞释放细胞因子。然而,关于嘌呤受体在小胶质细胞趋化因子释放中的作用知之甚少。在本研究中,我们发现高浓度的ATP可引起小鼠小胶质细胞系MG-5细胞释放CC趋化因子配体3(CCL3)/巨噬细胞炎性蛋白-1α,并且在ATP刺激后30分钟内可快速上调CCL3 mRNA。P2X(7)受体激动剂2'-和3'-O-(4-苯甲酰苯甲酰)ATP也可刺激CCL3的释放。P2X(7)受体拮抗剂亮蓝G强烈抑制这种ATP诱导的CCL3释放。在原代小胶质细胞中也观察到了类似的药理学特征。在MG-5细胞中,ATP导致转录因子活化T细胞核因子(NFAT)去磷酸化并发生核转位。ATP诱导的NFAT去磷酸化也依赖于P2X(7)受体激活。此外,NFAT的选择性抑制剂可阻止ATP诱导的CCL3释放和产生。综上所述,本研究结果表明NFAT参与了P2X(7)受体介导的CCL3释放机制。